Using germ-line genetic variation to investigate and treat cancer
- 31 July 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 9 (14) , 610-618
- https://doi.org/10.1016/s1359-6446(04)03179-4
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- The International HapMap ProjectNature, 2003
- A vision for the future of genomics researchNature, 2003
- Targeted therapy and pharmacogenomic programsCancer, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003
- Genetic epidemiology of female breast cancerSeminars in Cancer Biology, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- RARITY OF EWING'S SARCOMA AMONG U.S. NEGRO CHILDRENThe Lancet, 1970